Published in Cell Signal on June 01, 2001
Electrostatic sequestration of PIP2 on phospholipid membranes by basic/aromatic regions of proteins. Biophys J (2004) 2.66
Conversion of PtdIns(4,5)P(2) into PtdIns(5)P by the S.flexneri effector IpgD reorganizes host cell morphology. EMBO J (2002) 1.94
Kinetic analysis of receptor-activated phosphoinositide turnover. J Cell Biol (2003) 1.81
PtdIns5P activates the host cell PI3-kinase/Akt pathway during Shigella flexneri infection. EMBO J (2006) 1.45
Phosphatidylinositol 4-kinasebeta is critical for functional association of rab11 with the Golgi complex. Mol Biol Cell (2004) 1.39
Phosphatidylinositol-4,5-bisphosphate-rich plasma membrane patches organize active zones of endocytosis and ruffling in cultured adipocytes. Mol Cell Biol (2004) 1.32
A computational model for the electrostatic sequestration of PI(4,5)P2 by membrane-adsorbed basic peptides. Biophys J (2004) 1.32
Giant unilamellar vesicles containing phosphatidylinositol(4,5)bisphosphate: characterization and functionality. Biophys J (2008) 1.31
Molecular mechanism of an oncogenic mutation that alters membrane targeting: Glu17Lys modifies the PIP lipid specificity of the AKT1 PH domain. Biochemistry (2008) 1.30
Computational methods for biomolecular electrostatics. Methods Cell Biol (2008) 1.27
Phosphoinositides regulate membrane-dependent actin assembly by latex bead phagosomes. Mol Biol Cell (2002) 1.25
Regulation of C. elegans fat uptake and storage by acyl-CoA synthase-3 is dependent on NR5A family nuclear hormone receptor nhr-25. Cell Metab (2010) 1.18
myo-Inositol oxygenase: molecular cloning and expression of a unique enzyme that oxidizes myo-inositol and D-chiro-inositol. Biochem J (2001) 1.16
Increased concentration of polyvalent phospholipids in the adsorption domain of a charged protein. Biophys J (2004) 1.14
Type I phosphatidylinositol-4,5-bisphosphate 4-phosphatase regulates stress-induced apoptosis. Proc Natl Acad Sci U S A (2007) 1.10
Rapid turnover rate of phosphoinositides at the front of migrating MDCK cells. Mol Biol Cell (2008) 1.06
Stabilized phosphatidylinositol-5-phosphate analogues as ligands for the nuclear protein ING2: chemistry, biology, and molecular modeling. J Am Chem Soc (2007) 1.05
PERK utilizes intrinsic lipid kinase activity to generate phosphatidic acid, mediate Akt activation, and promote adipocyte differentiation. Mol Cell Biol (2012) 1.05
Quantitative analysis of the binding of ezrin to large unilamellar vesicles containing phosphatidylinositol 4,5 bisphosphate. Biophys J (2007) 1.04
Phosphoinositide phosphatases in a network of signalling reactions. Pflugers Arch (2007) 1.03
"Actin"g on GLUT4: membrane & cytoskeletal components of insulin action. Curr Diabetes Rev (2007) 1.02
Cell surface adenylate kinase activity regulates the F(1)-ATPase/P2Y (13)-mediated HDL endocytosis pathway on human hepatocytes. Cell Mol Life Sci (2006) 0.99
Overexpression of OSBP-related protein 2 (ORP2) induces changes in cellular cholesterol metabolism and enhances endocytosis. Biochem J (2005) 0.97
TCGAP, a multidomain Rho GTPase-activating protein involved in insulin-stimulated glucose transport. EMBO J (2003) 0.93
The intracellular localisation and mobility of Type Igamma phosphatidylinositol 4P 5-kinase splice variants. FEBS Lett (2006) 0.92
Domain formation in phosphatidylinositol monophosphate/phosphatidylcholine mixed vesicles. Biophys J (2004) 0.92
The PDZ2 domain of zonula occludens-1 and -2 is a phosphoinositide binding domain. Cell Mol Life Sci (2009) 0.92
SH2-containing inositol 5-phosphatases 1 and 2 in blood platelets: their interactions and roles in the control of phosphatidylinositol 3,4,5-trisphosphate levels. Biochem J (2003) 0.89
Bee Venom Phospholipase A₂: Yesterday's Enemy Becomes Today's Friend. Toxins (Basel) (2016) 0.88
Platelet lipidomics: modern day perspective on lipid discovery and characterization in platelets. Circ Res (2014) 0.86
Polyphosphoinositides-dependent regulation of the osteoclast actin cytoskeleton and bone resorption. BMC Cell Biol (2004) 0.86
Pharmacogenetics in model systems: defining a common mechanism of action for mood stabilisers. Prog Neuropsychopharmacol Biol Psychiatry (2005) 0.86
Phosphatidylinositol 4-phosphate 5-kinase α facilitates Toll-like receptor 4-mediated microglial inflammation through regulation of the Toll/interleukin-1 receptor domain-containing adaptor protein (TIRAP) location. J Biol Chem (2013) 0.86
Defining the role of a FYVE domain in the localization and activity of a cAMP phosphodiesterase implicated in osmoregulation in Trypanosoma cruzi. Mol Microbiol (2010) 0.86
Phosphatidylinositol 4,5-bisphosphate is a novel coactivator of the Pseudomonas aeruginosa cytotoxin ExoU. Infect Immun (2013) 0.84
Regulation of type II PIP kinase by PKD phosphorylation. Cell Signal (2006) 0.84
The nucleophosmin-anaplastic lymphoma kinase oncogene interacts, activates, and uses the kinase PIKfyve to increase invasiveness. J Biol Chem (2011) 0.83
A genomewide overexpression screen identifies genes involved in the phosphatidylinositol 3-kinase pathway in the human protozoan parasite Entamoeba histolytica. Eukaryot Cell (2014) 0.81
Whole genome association study identifies regions of the bovine genome and biological pathways involved in carcass trait performance in Holstein-Friesian cattle. BMC Genomics (2014) 0.81
Localization of phosphatidylinositol 4,5-bisphosphate to lipid rafts and uroids in the human protozoan parasite Entamoeba histolytica. Infect Immun (2013) 0.81
Phosphatidylinositol synthase is required for lens structural integrity and photoreceptor cell survival in the zebrafish eye. Exp Eye Res (2011) 0.81
Autophagy and endosomal trafficking inhibition by Vibrio cholerae MARTX toxin phosphatidylinositol-3-phosphate-specific phospholipase A1 activity. Nat Commun (2015) 0.81
Phosphatidylinositol-3,4,5-triphosphate and cellular signaling: implications for obesity and diabetes. Cell Physiol Biochem (2015) 0.80
Depletion of PtdIns(4,5)P₂ underlies retinal degeneration in Drosophila trp mutants. J Cell Sci (2013) 0.80
Dok-4 is a novel negative regulator of T cell activation. J Immunol (2009) 0.79
A novel mass assay to quantify the bioactive lipid PtdIns3P in various biological samples. Biochem J (2012) 0.79
Intermolecular interaction of phosphatidylinositol with the lipid raft molecules sphingomyelin and cholesterol. Biophysics (Nagoya-shi) (2008) 0.75
In vivo tracking of phosphoinositides in Drosophila photoreceptors. J Cell Sci (2015) 0.75
Phosphoinositides, Major Actors in Membrane Trafficking and Lipid Signaling Pathways. Int J Mol Sci (2017) 0.75
Myotubularin, a phosphatase deficient in myotubular myopathy, acts on phosphatidylinositol 3-kinase and phosphatidylinositol 3-phosphate pathway. Hum Mol Genet (2000) 1.92
Phosphoinositide kinase, diacylglycerol kinase, and phospholipase C activities associated to the cytoskeleton: effect of epidermal growth factor. J Cell Biol (1991) 1.75
Integrin-dependent translocation of phosphoinositide 3-kinase to the cytoskeleton of thrombin-activated platelets involves specific interactions of p85 alpha with actin filaments and focal adhesion kinase. J Cell Biol (1995) 1.57
Lsc is required for marginal zone B cells, regulation of lymphocyte motility and immune responses. Nat Immunol (2001) 1.41
Interaction of pp60c-src, phospholipase C, inositol-lipid, and diacyglycerol kinases with the cytoskeletons of thrombin-stimulated platelets. J Biol Chem (1991) 1.37
Lipid products of phosphoinositide 3-kinase interact with Rac1 GTPase and stimulate GDP dissociation. J Biol Chem (1998) 1.15
Phosphatidylinositol 3,4,5-trisphosphate-dependent stimulation of phospholipase C-gamma2 is an early key event in FcgammaRIIA-mediated activation of human platelets. J Biol Chem (1998) 1.10
Amino acid sequence and embryonic expression of msr/apj, the mouse homolog of Xenopus X-msr and human APJ. Mech Dev (1999) 1.07
Relationship between phosphoinositide kinase activities and protein tyrosine phosphorylation in plasma membranes from A431 cells. Biochem J (1990) 1.06
Involvement of platelet glycoprotein IIb-IIIa (alpha IIb-beta 3 integrin) in thrombin-induced synthesis of phosphatidylinositol 3',4'-bisphosphate. J Biol Chem (1991) 1.06
Production of phosphatidylinositol 3,4,5-trisphosphate and phosphatidic acid in platelet rafts: evidence for a critical role of cholesterol-enriched domains in human platelet activation. Biochemistry (2001) 1.05
Hypoxia-microRNA-16 downregulation induces VEGF expression in anaplastic lymphoma kinase (ALK)-positive anaplastic large-cell lymphomas. Leukemia (2011) 1.04
Characterisation of Rac activation in thrombin- and collagen-stimulated human blood platelets. FEBS Lett (2001) 1.02
Tyrosine phosphorylation and relocation of SHIP are integrin-mediated in thrombin-stimulated human blood platelets. J Biol Chem (1997) 1.00
The novel inositol lipid phosphatidylinositol 3,4-bisphosphate is produced by human blood platelets upon thrombin stimulation. Biochem J (1990) 1.00
A differential role of the platelet ADP receptors P2Y1 and P2Y12 in Rac activation. J Thromb Haemost (2005) 0.99
The integrin alpha IIb/beta 3 in human platelet signal transduction. Biochem Pharmacol (2000) 0.97
Familial adrenocorticotropin-independent macronodular adrenal hyperplasia with aberrant serotonin and vasopressin adrenal receptors. Eur J Endocrinol (2007) 0.94
Tyrosine kinases and phosphoinositide metabolism in thrombin-stimulated human platelets. Biochem J (1993) 0.90
[The Voice Handicap Index: impact of the translation in French on the validation]. Rev Laryngol Otol Rhinol (Bord) (2004) 0.90
Microtubule integrity regulates src-like and extracellular signal-regulated kinase activities in human pro-monocytic cells. Importance for interleukin-1 production. J Biol Chem (1998) 0.89
Association of phosphatidylinositol kinase and phosphatidylinositol 4-phosphate kinase activities with the cytoskeleton in human platelets. FEBS Lett (1989) 0.89
pp60c-src associates with the SH2-containing inositol-5-phosphatase SHIP1 and is involved in its tyrosine phosphorylation downstream of alphaIIbbeta3 integrin in human platelets. Biochem J (2000) 0.87
Phospholipase C from human sperm specific for phosphoinositides. Biochim Biophys Acta (1987) 0.87
FcgammaRIIA requires a Gi-dependent pathway for an efficient stimulation of phosphoinositide 3-kinase, calcium mobilization, and platelet aggregation. Blood (2000) 0.86
Studies of endogenous polyphosphoinositide hydrolysis in human platelet membranes. Evidence that polyphosphoinositides remain inaccessible to phosphodiesterase in the native membrane. Biochim Biophys Acta (1986) 0.85
Characterization of plasma membranes from A431 cells, isolated by self-generating Percoll gradient: a rapid isolation procedure to obtain plasma membranes with functional epidermal growth factor receptors. Biochim Biophys Acta (1988) 0.85
Intraoperative testosterone assay for virilizing ovarian tumor topographic assessment: report of a Leydig cell tumor of the ovary in a premenopausal woman with an adrenal incidentaloma. J Clin Endocrinol Metab (2002) 0.84
Inhibition of Rac controls NPM-ALK-dependent lymphoma development and dissemination. Blood Cancer J (2011) 0.84
Rho-kinase is involved in the sustained phosphorylation of myosin and the irreversible platelet aggregation induced by PAR1 activating peptide. Thromb Haemost (2001) 0.84
Inhibition of transmembrane movement and metabolism of platelet activating factor (PAF-acether) by a specific antagonist, BN 52021. Biochem Biophys Res Commun (1985) 0.83
Gi-dependent and -independent mechanisms downstream of the P2Y12 ADP-receptor. J Thromb Haemost (2004) 0.83
Combined hypothalamic-pituitary-gonadal defect in a hypogonadic man with a novel mutation in the DAX-1 gene. J Clin Endocrinol Metab (1999) 0.82
Effects of two methylxanthines, pentoxifylline and propentofylline, on arachidonic acid metabolism in platelets stimulated by thrombin. Biochem Pharmacol (1988) 0.82
Are polyphosphoinositides involved in platelet activation? Biochem Biophys Res Commun (1983) 0.82
Reversible translocation of phosphoinositide 3-kinase to the cytoskeleton of ADP-aggregated human platelets occurs independently of Rho A and without synthesis of phosphatidylinositol (3,4)-bisphosphate. J Biol Chem (1997) 0.81
Novel model of placental tissue explants infected by cytomegalovirus reveals different permissiveness in early and term placentae and inhibition of indoleamine 2,3-dioxygenase activity. Placenta (2011) 0.81
Phosphoinositide 3-kinase and integrin signalling are involved in activation of Bruton tyrosine kinase in thrombin-stimulated platelets. FEBS Lett (1999) 0.81
Phosphoinositide 3-phosphatase segregates from phosphatidylinositol 3-kinase in EGF-stimulated A431 cells and fails to in vitro hydrolyse phosphatidylinositol(3,4,5)trisphosphate. FEBS Lett (1994) 0.80
[Pseudomembranous rectocolitis and rifampicin]. Gastroenterol Clin Biol (1982) 0.79
Organization and role of platelet membrane phospholipids as studied with phospholipases A2 from various venoms and phospholipases C from bacterial origin. Toxicon (1982) 0.79
Paradoxical ovarian stimulations in the use of LHRH analogs. Eur J Obstet Gynecol Reprod Biol (1992) 0.79
Stimulation by epidermal growth factor of inositol phosphate production in plasma membranes from A431 cells. Biochim Biophys Acta (1991) 0.78
[Validation of a self assessment for speech disorders (Phonation Handicap Index)]. Rev Laryngol Otol Rhinol (Bord) (2009) 0.78
Increased levels of serum follicle-stimulating hormone and luteinizing hormone associated with intrinsic testicular hyperthermia in oligospermic infertile men. J Clin Endocrinol Metab (1989) 0.78
Joint Commission preparation in a large academic medical center: a framework for success. J Healthc Qual (1998) 0.78
Rapid and transient thrombin stimulation of phosphatidylinositol 4,5-bisphosphate synthesis but not of phosphatidylinositol 3,4-bisphosphate independent of phospholipase C activation in platelets. FEBS Lett (1993) 0.78
Asymmetry of arachidonic acid metabolism in the phospholipids of the human platelet membrane as studied with purified phospholipases. Biochim Biophys Acta (1982) 0.77
The platelet cytoskeleton regulates the aggregation-dependent synthesis of phosphatidylinositol 3,4-bisphosphate induced by thrombin. FEBS Lett (2000) 0.76
Rapid and transient translocation of PLC-gamma 1 to the cytoskeleton of thrombin-stimulated platelets. Evidence for a role of tyrosine kinases. Cell Mol Biol (Noisy-le-grand) (1994) 0.76
LH pulsatility and in vitro bioactivity in women with anorexia nervosa-related hypothalamic amenorrhea. Acta Endocrinol (Copenh) (1991) 0.76
Cationic amphiphilic drugs as a potential tool for modifying phospholipids of tumor cells. An in vitro study of chlorpromazine effects on Krebs II ascites cells. Biochem Pharmacol (1981) 0.75
Scrotal hyperthermia: frequency in an infertile population and associated alterations in testicular function. Adv Exp Med Biol (1991) 0.75
Inhibition of phosphatidylethanolamine biosynthesis by S-adenosylmethionine. FEBS Lett (1976) 0.75
[Expression of a new family of receptors similar to CXC chemokine receptors in endothelial cell precursors]. Pathol Biol (Paris) (1999) 0.75
Evidence for a glycoprotein IIb-IIIa- and aggregation-independent mechanism of phosphatidylinositol 3',4'-bisphosphate synthesis in human platelets. J Biol Chem (1995) 0.75
Calpains are involved in phosphatidylinositol 3',4'-bisphosphate synthesis dependent on the alpha IIb beta 3 integrin engagement in thrombin-stimulated platelets. FEBS Lett (1997) 0.75
Luteinizing hormone pulse frequency and in vitro bioactivity in male idiopathic infertility. Fertil Steril (1991) 0.75
Stimulation of phosphoinositide kinases by thrombin is restricted to the plasma membrane in platelets. Platelets (1998) 0.75
Platelet aggregation induced by the C-terminal peptide of thrombospondin-1 requires the docking protein LAT but is largely independent of alphaIIb/beta3. J Thromb Haemost (2003) 0.75
Inositol lipid metabolism, the cytoskeleton, glycoprotein IIb IIIa and platelets. Adv Exp Med Biol (1993) 0.75
Non specific effects of guanine nucleotides and polyanions on cytosolic platelet phospholipase C. Nouv Rev Fr Hematol (1992) 0.75
[Lasting increase of creatine kinase and its MB fraction without myocardial infarction]. Nouv Presse Med (1981) 0.75
Role of platelet membrane phospholipids in signal transduction. Agents Actions Suppl (1986) 0.75
[Erythema multiforme with mucous membrane involvement: responsibility of diclofenac?]. Ann Dermatol Venereol (1982) 0.75
Choriocarcinoma and endocrine paraneoplastic syndromes. Eur J Med (1994) 0.75
[Extrapyramidal syndrome. Possible role of metopimazine]. Presse Med (1983) 0.75
[Effects of pentoxifylline and propentofylline on the turnover of polyphosphoinositides of the erythrocyte membrane and on the metabolism of arachidonic acid in platelets]. Pathol Biol (Paris) (1988) 0.75
[Blood serum biochemistry of ponies (author's transl)]. Ann Rech Vet (1978) 0.75
Paradoxical ovarian stimulations in the use of LHRH analogs. Eur J Obstet Gynecol Reprod Biol (1992) 0.75
[Interactions of phosphorylethanolamine analogs with phosphorylethanolamine-citidylyltransferase]. Biochimie (1975) 0.75
[Joint manifestations of pefloxacin in adolescents]. Presse Med (1990) 0.75
[The frequency of alterations of the lipid and hydrocarbon levels in retinal detachment]. J Fr Ophtalmol (1978) 0.75
Studies on topological distribution of arachidonic acid replacement in platelet phospholipids and on enzymes involved in the phospholipid effect accompanying platelet activation. Agents Actions (1981) 0.75
Variation in the quantitation of prostate-specific antigen in reference material: differences in commercial immunoassays. Clin Chem (1998) 0.75
[Physiological values and sex variations of alkaline phosphatases during puberty]. Nouv Presse Med (1981) 0.75
[Stable bacterial variants. Evolutive cycle. Hypotheses]. Biol Med (Paris) (1970) 0.75
Characterization of [3H]idazoxan binding proteins in solubilized membranes from rabbit and human liver. J Auton Nerv Syst (1998) 0.75
Relationship between phospholipid metabolism and intracellular calcium mobilization during platelet activation. Nouv Rev Fr Hematol (1985) 0.75
[Hepatitis and autoimmune thrombopenia during treatment with clometacin]. Presse Med (1983) 0.75